Login

Getting Ahead of What Comes Next |Natalie Sandman,General Partner,Spark Capital 00:10:00

Share On Facebook Share On Twitter

Natalie Sandman is the General Partner, Early at Spark Capital.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Building and investing in early-stage companies|Edward Lando,Managing Partner,Pareto Holdings
00:10:00
Altius Minerals' Royalty Portfolio Positioned for Success | Brian Dalton , CEO, Altius Minerals Corp.
00:10:00
Eric's Journey from Product Management to Award-Winning CMO at Infinidat
00:10:00
Air France-KLM CEO Benjamin Smith at Skift Global Forum 2019 | Benjamin Smith, CEO, Air France-KLM .
00:10:00
How genomics will change the food industry|Barry Schuler,Partner,DFJ Growth
00:10:00
Challenging the Myths of the Great Depression|Amity Shlaes
00:10:00
James Femia of Apella Capital and Patrick Sweeny of Symmetry Partners discuss their collaboration and business practices.|Patrick A. Sweeny is a founding partner of Apella Capital.
00:10:00
June 18 Quarter Economic Update: Reflecting on Success and Strategic Positioning | Justin Hyland, Managing Director, Hyland Financial Planning.
00:10:00
Empowering Energy Sector Growth Through Efficiency and Strategic Investment | Daniel Pimentel Slaviero, CEO, Companhia Paranaense de Energia.
00:10:00
Expert.ai's CEO Walt Mayo provides an update on the company's FY20 results and discusses their ongoing technology development in a YouTube video by Edison, dated April 28, 2021.
00:10:00
Phil Corcoran's Role in Financial Advisory at Savant Wealth Management | Phil Corcoran, Managing Director, Savant Wealth Management.
00:10:00
Understanding the Evolution and Vision of XP Inc. | Thiago Maffra, CEO , XP Inc.

© 2017 - Neuhu+